Selenium Orotate

Selenium orotate is a chelated form of selenium bonded to orotic acid, designed to enhance cellular uptake and bioavailability compared to inorganic selenium salts. It exerts its primary effects through incorporation into selenoproteins such as glutathione peroxidase (GPx) and thioredoxin reductase (TrxR), which neutralize reactive oxygen species and regulate thyroid hormone metabolism.

Origin & History

Selenium orotate is a chelated mineral supplement combining the trace element selenium (atomic number 34) with orotic acid, a heterocyclic compound from pyrimidine biosynthesis. It is synthesized chemically by reacting orotic acid with inorganic selenium salts like selenious acid, forming an organometallic chelate designed for improved cellular transport.

Historical & Cultural Context

Selenium orotate has no traditional medicine history as it is a modern synthetic chelate developed post-1970s for the nutraceutical market. Elemental selenium itself has no documented role in traditional systems like Ayurveda or Traditional Chinese Medicine.

Health Benefits

• Antioxidant defense through selenoprotein activation (general selenium evidence, no orotate-specific trials) • Thyroid function support via selenoenzymes (based on general selenium RCTs, PMID: 30279399) • Potential cancer prevention properties (mixed outcomes in general selenium studies, n=1,312) • Cellular protection through glutathione peroxidase activity (mechanism-based, no orotate trials) • Enhanced bioavailability compared to inorganic selenium (theoretical based on chelation, unverified)

How It Works

Selenium from selenium orotate is incorporated as selenocysteine into selenoproteins, including the four glutathione peroxidase isoforms (GPx1–GPx4) and thioredoxin reductase 1–3, which catalyze the reduction of hydrogen peroxide and lipid hydroperoxides, limiting oxidative membrane damage. Selenoprotein P functions as a plasma selenium transporter and antioxidant, while iodothyronine deiodinases (DIO1, DIO2, DIO3) depend on selenocysteine to convert thyroxine (T4) to active triiodothyronine (T3). The orotic acid carrier may facilitate transport via monocarboxylate pathways, theoretically improving selenium retention in hepatic and thyroid tissues compared to selenite.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on selenium orotate were found in the research. General selenium research shows mixed outcomes for cancer prevention (PMID: 30279399, n=1,312) and benefits for thyroid function, but no data isolates the orotate form's efficacy.

Clinical Summary

No published randomized controlled trials exist specifically evaluating selenium orotate; available clinical evidence derives from trials using selenomethionine or sodium selenite. A Cochrane-reviewed RCT (PMID: 30279399, n=6,152 pooled) found selenomethionine supplementation at 200 mcg/day reduced thyroid antibody titers in Hashimoto's thyroiditis by approximately 49% versus placebo over 12 months. The Nutritional Prevention of Cancer (NPC) trial (n=1,312) reported a 63% reduction in prostate cancer incidence with 200 mcg/day selenium yeast, though the SELECT trial (n=35,533) found no benefit from selenomethionine at the same dose in a general population. Evidence for selenium orotate specifically remains extrapolated from these general selenium trials, and its claimed bioavailability advantage over selenomethionine has not been confirmed in head-to-head human trials.

Nutritional Profile

Selenium Orotate is a chelated mineral compound consisting of selenium (Se) bonded to orotic acid (vitamin B13 precursor). Typical supplemental doses provide 100–200 mcg elemental selenium per serving, with the orotate carrier contributing the remainder of the molecular weight (orotic acid MW ~156 g/mol; selenium MW ~79 g/mol). As a pure mineral chelate, it contains negligible macronutrients — effectively 0g protein, 0g fat, and 0g fiber per standard dose. The bioactive components are: (1) Elemental selenium (~25–35% by molecular weight depending on formulation), which serves as the catalytic cofactor for at least 25 known selenoproteins including glutathione peroxidases (GPx1–4), thioredoxin reductases (TrxR1–3), and iodothyronine deiodinases (DIO1–3); (2) Orotic acid, a pyrimidine precursor involved in nucleotide biosynthesis, present at approximately 65–75% of molecular weight. Bioavailability: Chelated selenium forms are theorized to offer improved intestinal absorption compared to inorganic forms (selenite, selenate) due to carrier-mediated transport pathways, though direct human bioavailability studies specific to selenium orotate are absent from published literature. General organic selenium bioavailability is estimated at 50–90% absorption efficiency versus ~50% for inorganic selenite. The Recommended Dietary Allowance (RDA) for selenium is 55 mcg/day for adults; the tolerable upper intake level (UL) is 400 mcg/day. Selenium orotate contains no vitamins, no dietary fiber, and negligible caloric content (<1 kcal per dose).

Preparation & Dosage

No clinically studied dosage ranges for selenium orotate are documented. General selenium supplementation uses 50-200 mcg/day elemental selenium across forms, with typical supplements claiming 50-200 mcg elemental Se per dose (3-12% Se by weight). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin E, methionine, vitamin C, zinc, glutathione

Safety & Interactions

Selenium toxicity (selenosis) can occur at chronic intakes above 400 mcg/day, manifesting as hair loss, nail brittleness, garlic-breath odor from dimethylselenide exhalation, peripheral neuropathy, and gastrointestinal disturbance. Selenium orotate may interact with cisplatin and other platinum-based chemotherapeutics, potentially altering their cytotoxic efficacy; concurrent use should be medically supervised. Anticoagulants such as warfarin may be potentiated by selenium supplementation due to effects on hepatic oxidative metabolism, warranting INR monitoring. Selenium crosses the placenta and is present in breast milk; supplementation during pregnancy should not exceed the tolerable upper intake level of 400 mcg/day and should only occur under physician guidance.